8-K/A XBRL

AMENDMENT NO. 1

Company: Alzamend Neuro, Inc.
Filed: April 20, 2022
Period of Report: April 20, 2022
Accession Number: 0001214659-22-005509

View Document ↗ View on SEC.gov ↗